MAGLI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 3.950
EU - Europa 3.031
AS - Asia 2.998
SA - Sud America 364
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 123
OC - Oceania 3
Totale 10.640
Nazione #
US - Stati Uniti d'America 3.791
SG - Singapore 1.253
RU - Federazione Russa 1.017
IT - Italia 1.004
CN - Cina 611
VN - Vietnam 574
DE - Germania 321
BR - Brasile 284
HK - Hong Kong 208
FR - Francia 155
NL - Olanda 111
CA - Canada 94
GB - Regno Unito 89
FI - Finlandia 84
IN - India 55
JP - Giappone 54
IE - Irlanda 52
BD - Bangladesh 50
CI - Costa d'Avorio 45
ES - Italia 44
PL - Polonia 32
KR - Corea 29
AR - Argentina 25
ID - Indonesia 23
MX - Messico 23
ZA - Sudafrica 23
SE - Svezia 21
MA - Marocco 20
PH - Filippine 20
EC - Ecuador 18
GR - Grecia 18
AT - Austria 17
TR - Turchia 15
TH - Thailandia 14
UA - Ucraina 14
CO - Colombia 13
IQ - Iraq 13
LT - Lituania 9
PK - Pakistan 9
TW - Taiwan 9
VE - Venezuela 9
IL - Israele 8
MY - Malesia 8
NI - Nicaragua 8
TN - Tunisia 8
BG - Bulgaria 7
HN - Honduras 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
JM - Giamaica 6
JO - Giordania 6
EE - Estonia 5
GT - Guatemala 5
KE - Kenya 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
CH - Svizzera 4
CL - Cile 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AZ - Azerbaigian 3
BE - Belgio 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
LB - Libano 3
LV - Lettonia 3
SV - El Salvador 3
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MN - Mongolia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CD - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 10.466
Città #
Singapore 651
San Jose 518
Ashburn 370
Naples 308
Chandler 246
Moscow 228
Beijing 203
Hong Kong 194
Council Bluffs 164
Santa Clara 154
Ho Chi Minh City 140
Hanoi 134
Hefei 126
Amsterdam 83
Napoli 81
Los Angeles 80
Dallas 71
The Dalles 61
Lauterbourg 60
New York 58
Millbury 52
Krefeld 46
Munich 44
Phoenix 42
Tokyo 41
São Paulo 34
Brooklyn 32
Helsinki 32
Milan 31
Nanjing 31
Princeton 31
Rome 31
Des Moines 30
Haiphong 30
Atlanta 29
Buffalo 28
Dong Ket 28
Frankfurt am Main 28
Redondo Beach 28
Boston 26
Toronto 25
Bad Bellingen 24
Falkenstein 24
Menlo Park 24
Chicago 23
Lawrence 23
Turku 23
Denver 22
Orem 22
Seoul 22
Ottawa 20
Da Nang 19
Warsaw 19
Houston 18
Pozzuoli 18
Casablanca 17
San Giorgio a Cremano 17
Wilmington 16
Chennai 15
London 15
Montreal 15
Mugnano di Napoli 15
Redwood City 15
Cambridge 14
Nuremberg 14
Mexico City 13
Dublin 12
Johannesburg 12
Manchester 11
Salerno 11
Stockholm 11
Thessaloniki 11
Trieste 11
San Francisco 10
Lappeenranta 9
North Bergen 9
Poplar 9
Vienna 9
Bangkok 8
Managua 8
Memphis 8
Mumbai 8
Nanchang 8
Rio de Janeiro 8
Dearborn 7
Ercolano 7
Falcone 7
Hải Dương 7
Jiaxing 7
Miami 7
Philadelphia 7
Roccarainola 7
Seattle 7
Washington 7
Zola Predosa 7
Athens 6
Birmingham 6
Bologna 6
Casoria 6
Frisco 6
Totale 5.376
Nome #
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 378
Quantitative determination of BPA, BPB, BPF and BPS levels in canned legumes from Italian market 347
Design, Synthesis and Biological Evaluation of Novel N-Arylpiperazines Containing a 4,5-Dihydrothiazole Ring 310
Monitoring of seven pesticide residues by LC-MS/MS in extra virgin olive oil samples and risk assessment for consumers 296
5-HT2 receptor affinity, docking studies and pharmacological evaluation of a series of 1,3-disubstituted thiourea derivatives 253
Phloroglucinol-Derived Medications are Effective in Reducing Pain and Spasms of Urinary and Biliary Tracts: Results of Phase 3 Multicentre, Open-Label, Randomized, Comparative Studies of Clinical Effectiveness and Safety 232
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents 225
Chemical Composition of PM10 at Urban Sites in Naples (Italy) 198
Synthesis of phenylpyrimidinones as guanylyl cyclase C inhibitors 194
Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments 183
HYBRIDS BETWEEN H2S-DONORS AND BETAMETHASONE 17-VALERATE OR TRIAMCINOLONE ACETONIDE: IN VITRO EFFECT IN ASTHMA TREATMENT 181
Antagonizing S1P3 receptor with cell-penetrating pepducins in skeletal muscle fibrosis 178
Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleus 177
Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength 176
A New Process for the Synthesis of Budesonide 21-Phosphate and Evaluation in a Murine Model of Inflammation 175
Heavy Metals Size Distribution in PM10 and Environmental-Sanitary Risk Analysis in Acerra (Italy) 175
The Role of 5-HT1A Receptor in the Cancer as a New Opportunity in Medicinal Chemistry 172
Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors 171
Synthesis, docking studies, and pharmacological evaluation of 5HT 2C ligands containing the N′-cyanoisonicotinamidine or N′-cyanopicolinamidine nucleus 169
New 5-HT1A, 5HT2Aand 5HT2Creceptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluation 166
Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents 165
Synthesis and Pharmacological Screening of Pyridopyrimidines as Effective Anti-Diarrheal Agents through the Suppression of Cyclic Nucleotide Accumulation 165
Synthesis, Chiral Resolution and Enantiomers Absolute Configuration of 4-Nitropropranolol and 7-Nitropropranolol 161
3-Nitroatenolol: First Synthesis, Chiral Resolution and Enantiomers’ Absolute Configuration 161
Development validation of LC-MS/MS method and determination of pharmacokinetic parameters of the stroke neuroprotectant neurounina-1 in beagle dog plasma after intravenous administration 161
Level, potential sources of polycyclic aromatic hydrocarbons (PAHs) in particulate matter (PM10) in Naples 160
Propafenone quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry in a bioequivalence study 160
5‑HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer 159
Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins 159
PCB levels in adipose tissue of dogs from illegal dumping sites in Campania region (Italy) 158
Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells 156
New Potent 5-HT2A Receptor Ligands Containing a N'-Cyanopicolinamidine Nucleus: Synthesis and In Vitro Pharmacological Evaluation 154
Design, synthesis and biological evaluation of TAR and cTAR binders as HIV-​1 nucleocapsid inhibitors 152
New Serotoninergic Ligands Containing Indolic and Methyl Indolic Nuclei: Synthesis and In Vitro Pharmacological Evaluation 151
Synthesis and In Vitro Pharmacological Evaluation of Novel 2-Hydroxypropyl-4-arylpiperazine Derivatives as Serotoninergic Ligands 149
Microwave Assisted Organic Synthesis of Heterocycles in Aqueous Media: Recent Advances in Medicinal Chemistry 148
New arylpiperazine derivatives with antidepressant-like activity containing isonicotinic and picolinic nuclei: evidence for serotonergic system involvement 146
Comparative Bioavailability Study of Two 81 mg Coated Tablet Formulations of Acetylsalicylic Acid in Fasting Healthy Volunteers 144
Arylpiperazine Derivatives and Cancer: A New Challenge in Medicinal Chemistry 142
Synthesis of benzamide derivatives and their evaluation as antiprion agents 141
Anti-metastatic properties of naproxen-HBTA in a murine model of cutaneous melanoma 141
Synthesis, in vitro and in vivo evaluation of 11C-O-methylated arylpiperazines as potential serotonin 1A (5-HT1A) receptor antagonist radiotracers 141
The Application of Microwaves, Ultrasounds, and Their Combination in the Synthesis of Nitrogen-Containing Bicyclic Heterocycles 140
Budesonide 21-phosphate sodium salt for use as anti-inflammatory or anti-asthmatic agent. 140
Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus 140
Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model 139
H2s donors and their use in medicinal chemistry 139
Trends in h2s-donors chemistry and their effects in cardiovascular diseases 137
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors 135
BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME 135
Technological and Physical–Chemical Evaluation of Cotton Gauzes Impregnated with Semisolid Preparations for Wound Healing 131
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 131
Synthesis of 1-naphthylpiperazine derivatives as serotoninergic ligands and their evaluation as antiproliferative agents. 129
Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production 129
Identification of a novel selective CSE inhibitor through a combined pharmacological and metabolomic approach 125
Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands 124
Serotoninergic receptor ligands improve Tamoxifen effectiveness on breast cancer cells 124
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 119
Multiple in Vitro Inhibition of HIV-1 Proteins by 2,6-Dipeptidyl-anthraquinone Conjugates Targeting the PBS RNA 116
New Insights into the Structure-Activity Relationship and Neuroprotective Profile of Benzodiazepinone Derivatives of Neurounina-1 as Modulators of the Na+/Ca2+Exchanger Isoforms 100
Efficient microwave combinatorial synthesis of novel indolic arylpiperazine derivatives as serotoninergic ligands 98
Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus. 87
Process for the preparation of budesonide 21-phosphate 82
New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: Synthesis and in vitro pharmacological evaluation 71
Quantitative analysis of pesticide residues in wine grapes during a downy mildew infestation using LC-MS/MS and associated risk assessment 49
Novel 1,4-benzothiazepin-2-one modulators of NCX3 as a promising strategy for neuroprotection in cerebral ischemia 47
Once Upon a Time Without DMF: Greener Paths in Peptide and Organic Synthesis 36
Improved Synthesis of 5-Nitrohomovanillic Acid and 6-Nitrohomovanillic Acid as Probes for Metabolism Studies of Endothelium-Derived Dopamines: Identification in Human Amniotic Fluid 34
Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents 34
A resveratrol–hydrogen sulfide donor hybrid as a multi-target therapeutic strategy for allergic asthma 21
Novel 4,5‐Dihydrothiazole‐Phenylpiperazine Derivatives: Synthesis, Docking Studies and Pharmacological Evaluation as Serotonergic Agents 18
Totale 10.640
Categoria #
all - tutte 33.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022343 0 0 0 0 11 16 3 14 44 36 103 116
2022/2023606 61 86 11 50 53 56 13 56 96 68 39 17
2023/2024658 17 65 96 16 14 15 47 58 207 19 68 36
2024/20252.363 97 125 33 52 69 162 207 168 156 264 855 175
2025/20264.292 425 303 488 386 705 148 495 200 575 310 153 104
2026/20271.483 128 402 244 466 243 0 0 0 0 0 0 0
Totale 10.640